Materia Medica Holding
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-20
ACTIVE TRIALS5
PHASE 3 / 2-35
RECRUITING4
READOUTS ≤12 MONTHS1
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| Raphamin NCT06284265 |
P3 | Active, not recruiting | Cystitis Chronic; Cystitis Bacterial | 415 | 2026-12-31 |
| Raphamin NCT06901297 |
P3 | Recruiting | Rhinosinusitis; Rhinosinusitis Acute | 552 | 2027-12-31 |
| Raphamin NCT06715891 |
P3 | Recruiting | Acute Respiratory Viral Infection | 374 | 2027-12-31 |
| Rengalin NCT07171099 |
P3 | Recruiting | Cough | 264 | 2028-12-31 |
| Raphamin NCT07650227 |
P3 | Recruiting | Bronchitis; Acute Bronchitis | 308 | 2028-12-31 |